Oppenheimer Maintains SKYE BIOSCIENCE INC(SKYE.US) With Buy Rating, Maintains Target Price $21

Futu NewsNov 8 22:38 · Ratings

Skye Bioscience Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results.

BenzingaNov 8 22:37

Skye Bioscience GAAP EPS of -$0.10 Beats by $0.15

Seeking AlphaNov 8 06:05

SKYE BIOSCIENCE INC | 10-Q: Quarterly report

SECNov 8 05:17 · Announcements

Press Release: Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights

Dow JonesNov 8 05:01

Skye Bioscience Q3 2024 Earnings Preview

Seeking AlphaNov 7 06:20